By Government Contracts Editorial Staff
ModernaUS Inc., Cambridge, Massachusetts, was awarded a $1,966,598,000 modification for the purchase of an additional 100 million filled drug production doses of SARS-CoV-2 mRNA-1273 vaccine utilizing Option 1 and acetate efforts on the base and option. Work will be performed in Cambridge, Massachusetts, with an estimated completion date of June 30, 2021. Fiscal 2021 research, development, test and evaluation funds in the amount of $1,966,598,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity.
Interested in submitting an article?
Submit your information to us today!Learn More